Literature DB >> 21626327

Aluminum potassium sulfate and tannic acid (ALTA) injection as the mainstay of treatment for internal hemorrhoids.

Yoshikazu Hachiro1, Masao Kunimoto, Tatsuya Abe, Masahiro Kitada, Yoshiaki Ebisawa.   

Abstract

PURPOSE: Aluminum potassium sulfate and tannic acid (ALTA) induce noninvasive sclerosis and the involution of hemorrhoids by initiating an inflammatory reaction. We assessed the mid-term outcome after ALTA sclerotherapy for symptomatic hemorrhoids.
METHODS: Between May 2006 and July 2009, 1210 patients with grade III or IV hemorrhoids underwent surgery at Kunimoto Hospital. Our treatment strategy for internal hemorrhoids is first establishing whether ALTA therapy is possible for the type of hemorrhoid, and then performing either ALTA therapy or alternatively, ligation and excision (LE) for those types unsuitable for ALTA therapy.
RESULTS: A total of 448 patients were treated with ALTA therapy alone (Group A), 706 patients were treated with a combination of ALTA and LE therapy (Group B), and 56 patients were treated with LE alone (Group C). The overall recurrence rates were 3.6% (16/448) and 0.3% (2/706) in Groups A and B, respectively. There was no recurrence in Group C. Rectal ulcers developed at the injection site in four (0.9%) patients from Group A, but they healed within a few months with conservative therapy.
CONCLUSION: ALTA sclerotherapy is a simple and safe treatment for symptomatic hemorrhoids, with few complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626327     DOI: 10.1007/s00595-010-4386-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Prospective randomized multicentre trial comparing stapled with open haemorrhoidectomy.

Authors:  E Ganio; D F Altomare; F Gabrielli; G Milito; S Canuti
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  Sclerosing therapy of internal hemorrhoids with a novel sclerosing agent. Comparison with ligation and excision.

Authors:  M Takano; J Iwadare; H Ohba; H Takamura; Y Masuda; K Matsuo; T Kanai; H Ieda; Y Hattori; S Kurata; S Koganezawa; K Hamano; S Tsuchiya
Journal:  Int J Colorectal Dis       Date:  2005-04-21       Impact factor: 2.571

3.  Randomized clinical trial of stapled versus Milligan-Morgan haemorrhoidectomy.

Authors:  R Shalaby; A Desoky
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

4.  Sclerosing effect of OC-108, a novel agent for hemorrhoids, is associated with granulomatous inflammation induced by aluminum.

Authors:  Takashi Ono; Kazuko Goto; Shiro Takagi; Shigeo Iwasaki; Hirotsugu Komatsu
Journal:  J Pharmacol Sci       Date:  2005-11-26       Impact factor: 3.337

5.  The outcome of postoperative hemorrhaging following a hemorrhoidectomy.

Authors:  Takaaki Yano; Yasuhide Matsuda; Michio Asano; Kazuhiko Kawakami; Katsuhiko Nakai; Masahiko Nonaka; Kouzou Kimura; Kazuhide Yoshihara
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

  5 in total
  16 in total

1.  Partial stapled hemorrhoidopexy: a minimally invasive technique for hemorrhoids.

Authors:  Hong-Cheng Lin; Qiu-Lan He; Dong-Lin Ren; Hui Peng; Shang-Kui Xie; Dan Su; Xiao-Xue Wang
Journal:  Surg Today       Date:  2011-12-08       Impact factor: 2.549

2.  Outcomes of case-matched injection sclerotherapy with a new agent for hemorrhoids in patients treated with or without blood thinners.

Authors:  T Yano; T Nogaki; M Asano; S Tanaka; K Kawakami; Y Matsuda
Journal:  Surg Today       Date:  2012-10-10       Impact factor: 2.549

3.  Cap-assisted endoscopic sclerotherapy for hemorrhoids: Methods, feasibility and efficacy.

Authors:  Ting Zhang; Li-Juan Xu; Jie Xiang; Zhi He; Zhao-Yuan Peng; Guang-Ming Huang; Guo-Zhong Ji; Fa-Ming Zhang
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

4.  Prospective study comparing the new sclerotherapy and hemorrhoidectomy in terms of therapeutic outcomes at 4 years after the treatment.

Authors:  T Yano; M Asano; S Tanaka; N Oda; Y Matsuda
Journal:  Surg Today       Date:  2013-03-30       Impact factor: 2.549

5.  Comparison of topical anesthetic cream (EMLA) and diclofenac suppository for pain relief after hemorrhoidectomy: a randomized clinical trial.

Authors:  Mojgan Rahimi; Ali Reza Kazemeini; Nasim Pourtabatabaei; Amir Reza Honarmand
Journal:  Surg Today       Date:  2012-06-19       Impact factor: 2.549

6.  Serum aluminum levels in dialysis patients after sclerotherapy of internal hemorrhoids with aluminum potassium sulfate and tannic acid.

Authors:  Akira Tsunoda; Masafumi Nakagi; Nobuyasu Kano; Masahiko Mizutani; Kenji Yamaguchi
Journal:  Surg Today       Date:  2014-05-11       Impact factor: 2.549

7.  Visualization of diffusion of the drug solution during aluminum potassium tannic acid injection therapy: a pilot study.

Authors:  Yutaka Yamamoto; Mitsuharu Miwa
Journal:  Surg Today       Date:  2012-12-11       Impact factor: 2.549

8.  Aluminum potassium sulfate and tannic acid sclerotherapy for Goligher Grades II and III hemorrhoids: Results from a multicenter study.

Authors:  Hidenori Miyamoto; Takenori Hada; Gentaro Ishiyama; Yoshito Ono; Hideo Watanabe
Journal:  World J Hepatol       Date:  2016-07-18

9.  Modified LigaSure hemorrhoidectomy for the treatment of hemorrhoidal crisis.

Authors:  Chuang-Wei Chen; Chieh-Wen Lai; Yao-Jen Chang; Koung-Hong Hsiao
Journal:  Surg Today       Date:  2013-06-29       Impact factor: 2.549

10.  Treatment of Internal Hemorrhoids by Endoscopic Sclerotherapy with Aluminum Potassium Sulfate and Tannic Acid.

Authors:  Yuichi Tomiki; Seigo Ono; Jun Aoki; Rina Takahashi; Shun Ishiyama; Kiichi Sugimoto; Yukihiro Yaginuma; Yutaka Kojima; Michitoshi Goto; Atsushi Okuzawa; Kazuhiro Sakamoto
Journal:  Diagn Ther Endosc       Date:  2015-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.